These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19587802)

  • 1. Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis.
    Fleming JN; Shulman HM; Nash RA; Johnson PY; Wight TN; Gown A; Schwartz SM
    PLoS One; 2009 Jul; 4(7):e6203. PubMed ID: 19587802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
    Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Adenosine Deaminase Ameliorates Inflammation, Vascular Disease, and Fibrosis in Preclinical Models of Systemic Sclerosis.
    Zhang Y; Zhu H; Layritz F; Luo H; Wohlfahrt T; Chen CW; Soare A; Bergmann C; Ramming A; Groeber F; Reuter C; Fornasini G; Soukhareva N; Schreiber B; Ramamurthy S; Amann K; Schett G; Distler JHW
    Arthritis Rheumatol; 2020 Aug; 72(8):1385-1395. PubMed ID: 32182396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells.
    Mazzotta C; Manetti M; Rosa I; Romano E; Blagojevic J; Bellando-Randone S; Bruni C; Lepri G; Guiducci S; Ibba-Manneschi L; Matucci-Cerinic M
    Arthritis Res Ther; 2017 Feb; 19(1):27. PubMed ID: 28183357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nodular Sclerodermatous Chronic Cutaneous Graft-Versus-Host Disease (GvHD): A New Clinicopathological Variant of Cutaneous Sclerodermatous GvHD Resembling Nodular/Keloidal Scleroderma.
    Prieto-Torres L; Boggio F; Gruber-Wackernagel A; Cerroni L
    Am J Dermatopathol; 2017 Dec; 39(12):910-913. PubMed ID: 28475513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T follicular helper-like cells contribute to skin fibrosis.
    Taylor DK; Mittereder N; Kuta E; Delaney T; Burwell T; Dacosta K; Zhao W; Cheng LI; Brown C; Boutrin A; Guo X; White WI; Zhu J; Dong H; Bowen MA; Lin J; Gao C; Yu L; Ramaswamy M; Gaudreau MC; Woods R; Herbst R; Carlesso G
    Sci Transl Med; 2018 Mar; 10(431):. PubMed ID: 29514998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular damage and lack of angiogenesis in systemic sclerosis skin.
    Konttinen YT; Mackiewicz Z; Ruuttila P; Ceponis A; Sukura A; Povilenaite D; Hukkanen M; Virtanen I
    Clin Rheumatol; 2003 Sep; 22(3):196-202. PubMed ID: 14505210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide.
    Borghini A; Manetti M; Nacci F; Bellando-Randone S; Guiducci S; Matucci-Cerinic M; Ibba-Manneschi L; Weber E
    PLoS One; 2015; 10(6):e0130166. PubMed ID: 26076019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolution of Skin Fibrosis by Neutralization of the Antifibrinolytic Function of Plasminogen Activator Inhibitor 1.
    Lemaire R; Burwell T; Sun H; Delaney T; Bakken J; Cheng L; Rebelatto MC; Czapiga M; de-Mendez I; Coyle AJ; Herbst R; Lafyatis R; Connor J
    Arthritis Rheumatol; 2016 Feb; 68(2):473-83. PubMed ID: 26414805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial-cell injury in cutaneous acute graft-versus-host disease.
    Dumler JS; Beschorner WE; Farmer ER; Di Gennaro KA; Saral R; Santos GW
    Am J Pathol; 1989 Dec; 135(6):1097-103. PubMed ID: 2596572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nailfold capillary abnormalities in sclerodermatous chronic GVHD.
    Hofstee HM; de Waal TT; Zweegman S; Voskuyl AE; Smulders YM; Schoordijk MC; Janssen JJ; Serné EH
    Bone Marrow Transplant; 2013 Nov; 48(12):1574-7. PubMed ID: 23892332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis.
    Noda S; Asano Y; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    PLoS One; 2012; 7(2):e32272. PubMed ID: 22384200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases-systemic sclerosis and sclerodermatous graft-versus-host disease.
    Yang H; Cheong S; He Y; Lu F
    Stem Cell Res Ther; 2023 Dec; 14(1):372. PubMed ID: 38111001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis.
    Yamashita T; Asano Y; Saigusa R; Taniguchi T; Nakamura K; Miura S; Toyama T; Takahashi T; Ichimura Y; Hirabayashi M; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    J Dermatol Sci; 2019 Jan; 93(1):24-32. PubMed ID: 30270117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis.
    Manetti M; Guiducci S; Ibba-Manneschi L; Matucci-Cerinic M
    J Cell Mol Med; 2010 Jun; 14(6A):1241-54. PubMed ID: 20132409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis.
    Ponsoye M; Frantz C; Ruzehaji N; Nicco C; Elhai M; Ruiz B; Cauvet A; Pezet S; Brandely ML; Batteux F; Allanore Y; Avouac J
    Ann Rheum Dis; 2016 Dec; 75(12):2142-2149. PubMed ID: 26912566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial Response to Type I Interferon Contributes to Vasculopathy and Fibrosis and Predicts Disease Progression of Systemic Sclerosis.
    Yin H; Distler O; Shen L; Xu X; Yuan Y; Li R; Liu B; Li Q; Huang Q; Xie F; Zhang Z; Liang R; Dai X; Chen X; Li B; Yan Q; Lu L
    Arthritis Rheumatol; 2024 Jan; 76(1):78-91. PubMed ID: 37488975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis.
    Romano E; Manetti M; Rosa I; Fioretto BS; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Ann Rheum Dis; 2018 Nov; 77(11):1665-1674. PubMed ID: 30021803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular leak is a central feature in the pathogenesis of systemic sclerosis.
    Frech TM; Revelo MP; Drakos SG; Murtaugh MA; Markewitz BA; Sawitzke AD; Li DY
    J Rheumatol; 2012 Jul; 39(7):1385-91. PubMed ID: 22660809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis.
    Corallo C; Franci B; Lucani B; Montella A; Chirico C; Gonnelli S; Nuti R; Giordano N
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):93-103. PubMed ID: 25816411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.